Navigation Links
Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
Date:11/3/2008

Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications. The company expects that the first microRNA diagnostic tests applying its technology will be launched by licensed clinical laboratories in the United States in 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the expected timing of submission for approval and launch of diagnostic tests using our microRNA technology constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of whic
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
2. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
3. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
4. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
5. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
8. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
9. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
10. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
11. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Look inside ... hard-working items for the lab, from fluid handling to ... (GIS)—ready to ship when you order. , Preferred ... Pumps , from the L/S® model for precise flow ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA theory ... of these latent viruses is the Epstein Barr Virus (EBV), ... arthritis (RA) is a chronic inflammatory disease that destroys the ... that RA patients have high concentrations of EBV DNA in ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider ... treatment of tinnitus. Patients listen to sound therapy that ... period of weeks to months, their tinnitus volume decreases. , ... Notched Music and Notched White Noise. Now, AudioNotch is pleased ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... March 20, 2012 /PRNewswire-iReach/ -- Systems Alliance, ... build, assess and optimize online properties, today announced it ... The Living Legacy Foundation . The non-profit organization facilitates ... for transplantation and research in Maryland with the exception ...
... FULTON, Miss., March 20, 2012  Frank A. Critz, M.D., founder ... honored with a hometown hero,s welcome this April when he ... prostate cancer survivors.  The event will be April 14, 2012 ... Street in Fulton from noon until 3 p.m., and lunch ...
... 2012 GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an ... fight Human Immunodeficiency Virus (HIV) infections, announced today ... certain institutional investors, pursuant to which the Company ... A convertible preferred stock at an aggregate purchase ...
Cached Biology Technology:Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland 2Systems Alliance Launches Redesigned Website for The Living Legacy Foundation of Maryland 3Radiotherapy Clinics of Georgia's Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award 2GeoVax Announces Private Placement of $2.2 Million 2GeoVax Announces Private Placement of $2.2 Million 3GeoVax Announces Private Placement of $2.2 Million 4
(Date:7/9/2014)... some shark species may be able to cope with the ... temperatures. , The Arctic today is best known for its ... that. Roughly 53 to 38 million years ago during what ... similar to a huge temperate forest with brackish water, home ... hippo-like creatures, crocodiles and giant tortoises. Much of what is ...
(Date:7/9/2014)... The U.S. may be on the verge of an economy ... burns cleaner than coal and is undergoing a production boom. ... globally, but recent research is casting serious doubts over just ... Chemical & Engineering News (C&EN), the weekly news magazine ... Johnson, a senior correspondent at C&EN, explains that when burned ...
(Date:7/9/2014)... can alleviate the symptoms of Alzheimer,s disease, ... and effectively scavenge amyloid beta peptide in ... reduced and eliminated Aβ deposition in an ... significantly improved behavioral and cognitive impairment. Dr. ... Hospital of China Medical University, China immunized ...
Breaking Biology News(10 mins):Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
... -- The Society of Environmental Toxicology and Chemistry will present ... its 33rd Annual Meeting, November 11 at the Long Beach ... the Rosenstiel School of Marine & Atmospheric Science of the ... to the understanding of fate and effects of metals in ...
... Four young scientists have received postdoctoral fellowships from the ... program, they conduct research with the eventual aim of ... receiving mentorship from a faculty member at their home ... seven research teams. This allows them to interact with ...
... 2012  Verinata Health, Inc., a privately-held company dedicated to ... at the 62 nd Annual Meeting of the ... being held in San Francisco, California. (Logo: ... offers pregnant women access to a blood test that ...
Cached Biology News:SETAC announces Chris Lee Award for metals research winner, Kevin Brix 2Space research institute awards postdoctoral fellowships to 4 scientists 2Verinata Health Announces New Findings At The American Society Of Human Genetics 2
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
... Multipeptide Kit, designed for use with ... variety of amyloid peptides more straightforward ... Clinical neuroscience proteomics applications - Monitor ... Correlate beta-amyloid peptide levels with disease ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... Biosystems and MDS Sciex present the ... high performance hybrid triple quadrupole/linear ion ... discovery, drug development or proteomics researcher. ... from the leaders in mass spectrometry ...
Biology Products: